Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerization

ChemMedChem. 2010 Nov 8;5(11):1899-906. doi: 10.1002/cmdc.201000308.

Abstract

Herein we describe the synthesis and HIV-1 protease (PR) inhibitory activity of 16 new peptidomimetic molecular tongs with a naphthalene scaffold. Their peptidic character was progressively decreased. Two of these molecules exhibited the best dimerization inhibition activity toward HIV-1 wild-type and multimutated ANAM-11 proteases obtained to date for this class of molecules (∼40 nM for wild-type PR and 100 nM for ANAM-11 PR). Although the peptidic character of one molecular tong was completely suppressed, the mechanism of inhibition and inhibitory potency toward both proteases were maintained.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections / drug therapy*
  • HIV Protease / chemistry*
  • HIV Protease / classification
  • HIV Protease / genetics
  • HIV Protease Inhibitors / chemistry
  • HIV Protease Inhibitors / pharmacology
  • HIV Protease Inhibitors / therapeutic use*
  • Hydrophobic and Hydrophilic Interactions
  • Inhibitory Concentration 50
  • Molecular Mimicry
  • Mutation / drug effects*
  • Naphthalenes / chemistry
  • Naphthalenes / pharmacology
  • Naphthalenes / therapeutic use
  • Protein Binding / drug effects
  • Protein Multimerization / drug effects*

Substances

  • HIV Protease Inhibitors
  • Naphthalenes
  • HIV Protease